Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
34 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsEUROPEAN COMMISSION APPROVES MARKETING AUTHORISATION FOR VELTASSAŽ
(WorldNews Switzerland)

 
 

21 july 2017 08:09:12

 
EUROPEAN COMMISSION APPROVES MARKETING AUTHORISATION FOR VELTASSAŽ
(WorldNews Switzerland)
 


Veltassa approved for marketing in the EU for hyperkalaemia First launches planned from the end of 2017 or early 2018 Veltassa to be European brand name THE EUROPEAN COMMISSION HAS APPROVED PATIROMER TO BE MARKETED AS VELTASSA IN THE 28 EU COUNTRIES FOR THE TREATMENT OF ELEVATED SERUM POTASSIUM LEVELS (HYPERKALAEMIA) IN ADULT PATIENTS. THE APPROVAL IS ALSO ACCEPTED IN NORWAY, ICELAND AND LIECHTENSTEIN. Veltassa is a sodium-free potassium binder approved for the treatment of hyperkalaemia in adult patients. This therapy can also be made available to patients who develop hyperkalaemia while being treated with renin angiotensin aldosterone system (RAAS) inhibitor therapy. Nearly 100% of...


 
35 viewsCategory: General > Europe > Switzerland
 
2017 first-half-year results
(WorldNews Switzerland)
Letter: My response to Cherry Pacquette`s letter to Sam Raphael
(WorldNews Switzerland)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten